|
|
20083
|
INSTARYL D SYRUP
|
DEXTROMETHORPHAN HYDROBROMIDE B.P. CHLORPHENAMINE MALEATE B.P. GUAIFENESIN B.P. AND AMMONIUM CHLORIDE B.P.
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
19842
|
INSTARYL EXPECTORANT
|
SALBUTAMOL SULPHATE B.P. BROMHEXINE HYDROCHLORIDE B.P. PHENYLEPHRINE HYDROCHLORIDE B.P.
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
CTD6868
|
INSTGRA
|
-
|
LAZOR PHARMACEUTICALS LIMITED
|
Registered
|
Details →
|
|
|
H2020/CTD6868/13226
|
INSTGRA
|
DOLUTEGRAVIR SODIUM
|
LAZOR PHARMACEUTICALS LIMITED
|
Registered
|
Details →
|
|
|
H2012/CTD129/013
|
INSUGEN-30/70
|
INSULIN INJECTION BIPHASIC ISOPHANE PH.EUR.
|
SYNER-MED PHARMACEUTICALS (K)LTD
|
Registered
|
Details →
|
|
|
H2012/CTD127/011
|
INSUGEN-N
|
INSULIN INJECTION ISOPHANE
|
SYNER-MED PHARMACEUTICALS (K)LTD
|
Registered
|
Details →
|
|
|
H2012/CTD128/012
|
INSUGEN-R
|
INSULIN INJECTION SOLUBLE PH.EUR.
|
SYNER-MED PHARMACEUTICALS (K)LTD
|
Registered
|
Details →
|
|
|
20710
|
INSUGET 70/30
|
HUMAN INSULIN
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2009/20709/330
|
INSUGET N INJECTION
|
HUMAN INSULIN RDNA
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
H2009/20708/330
|
INSUGET R INJECTION
|
HUMAN INSULIN RDNA ORIGIN
|
HARLEYS LTD-NAIROBI
|
Registered
|
Details →
|
|
|
5891
|
INSULATARD
|
INSULIN HUMAN (PH. EUR.)
|
PHILLIPS THERAPEUTICS LIMITED
|
Registered
|
Details →
|
|
|
5893
|
INSULATARD PENFILL & FLEXPEN, 100 IU/ML (5 X 3ML)
|
INSULIN HUMAN (PH. EUR.)
|
PHILLIPS THERAPEUTICS LIMITED
|
Registered
|
Details →
|
|
|
20368
|
INSUMAN BASAL 100 IU/ML
|
RECOMBINANT HUMAN INSULIN (ISOPHANE INSULIN SUSPENSION)
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2015/CTD1653/255
|
INSUMAN COMB 30, 3ML CARTRIDGE
|
INSULIN HUMAN
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2015/CTD736/244
|
INSUMAN RAPID 100 IU/ML, VIAL
|
INSULIN HUMAN
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H94/320
|
INTACYCLINE SKIN OINTMENT
|
TETRACYCLINE HCL
|
REGAL PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2026/CTD9024/18339
|
INTAFERON INJECTION
|
IRON SUCROSE USP
|
CROWN HEALTHCARE
|
Registered
|
Details →
|
|
|
H2012/CTD494/219
|
INTAFUNGI LIPID SUSPENSION FOR INJECTION
|
NANOSOMAL AMPHOTERICIN B
|
ACCORD HEALTHCARE (K) LTD
|
Registered
|
Details →
|
|
|
H2019/CTD5926/1130ER
|
INTAMAB 100 I.V INFUSION
|
RITUXIMAB
|
ACCORD HEALTHCARE (K) LTD
|
Registered
|
Details →
|
|
|
H2019/CTD5926/1130ER/R1
|
INTAMAB 100 I.V INFUSION
|
RITUXIMAB
|
INTAS PHARMACEUTICALS LTD
|
Retained
|
Details →
|